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Abstract: The potential use as a bone substitute material of a three-dimensional bioactive 
glass fibre scaffold composed of Na2O–K2O–MgO–CaO–B2O3–P2O5–SiO2 (BG1) was 
investigated in this work. Scaffolds were pre-treated with simulated body fluid (SBF) to 
promote the formation of two different bone-like apatite layers on their surfaces. The 
topography and roughness of the deposited layers were assessed by scanning electron 
microscopy (SEM), while the chemical composition and structure using X-ray photoelectron 
spectroscopy (XPS) and Raman spectroscopy, respectively. Based on surface analysis, the 
bioactive glass surfaces were ranked from smoothest to roughest: 0 SBF (untreated), 1x SBF 
and 2x SBF. A calcium-deficient carbonated hydroxyapatite (HCA) layer was present on both 
SBF treated scaffolds, with higher number and larger bone-like apatite nodule formation in 
the 2x SBF case. MC3T3-E1 preosteoblasts showed a more flattened morphology and higher 
cell proliferation on the non treated scaffolds, whereas cells were more elongated and had 
higher osteoblastic activity on SBF-treated samples. In vivo results in a rabbit calvarial bone 
defect model showed enhanced bone formation with SBF pre-treated scaffolds, compared to 
untreated ones, commercially available Perioglassparticles and empty defects. Our findings 
demonstrate that the formation of a rough HCA layer on bioactive glass porous scaffolds 
enhanced preosteoblast maturation in vitro, as well as bone formation in vivo.  
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INTRODUCTION 
 More than one million patients are treated every year to manage bone defects of 
congenital origin, generated after tumor resection and fractures, as well as to perform spine 
fusions, and to restore osseous sites in joint and dental implantology.1 The standard 
approaches currently use bone autografts. They have inherent limitations, including 
availability of graft material and non-optimal shape, requirement of secondary surgery to 
access autograft material, extended patient recovery time and site morbidity.2  Allogenic bone 
or xenogenic grafts have been considered as an alternative. However, they still pose the risk 
of disease transmission, loss of biological and mechanical properties following explantation, 
and high costs, which altogether limit their use.3  
 An ideal scaffold for bone regeneration is biocompatible and provides a three-
dimensional network for cells and bone to grow within it, namely by the creation of an 
interconnected macroporous structure with pore diameter of at least 100 m. Furthermore, it 
should promote cell adhesion and activity, ideally towards the osteoblastic phenotype, resorb 
along with new bone formation, and its mechanical properties should match those at the 
implantation site.3 In efforts to develop alternative materials for bone autografts, synthetic 
bone substitute scaffolds constitute promising candidates. In this respect, many materials are 
being currently studied including natural and synthetic polymers, inorganic materials and 
composites. In the field of inorganic biomaterials, besides ceramics and calcium phosphates 
(i.e. hydroxyapatite (HAP), tricalcium phosphate), bioactive glasses appear to be promising 
bone substitutes.4 They are able to promote osteoconduction, since they allow for direct bone 
bonding and in-growth, as well as sufficient vascularization. Moreover, they are bioresorbable 
and have potential osteoproductive properties, which provide a good environment for bone 
cells to grow and differentiate.5  
 By definition, the “bioactivity” associated with bioactive glass materials relates to 
their ability to elicit a specific biological response at the interface of the material, which 
  
results in the formation of a direct bond to the tissues surrounding it.6 This process starts 
when bioactive glasses are immersed into biological fluids in vivo or simulated body fluid 
(SBF), cell culture medium or other buffered electrolyte solutions in vitro. In these cases, a 
series of events occur via ion leaching and exchange with the surrounding solution, which 
lead to calcium phosphate precipitation and final bone-like apatite layer formation onto the 
bioactive glass surface.7,8  This ionic dissolution, together with the slight alkalinization 
thereby induced,9 have been associated with the osteoproductive properties of bioactive 
glasses. 
 Most of the bioactive glasses studied so far have a particulate shape (i.e. Novabone, 
Perioglass), or are produced in form of block material, which is difficult to shape and has a 
very low surface area to volume ratio (SA/V). The particulate material can easily adapt to any 
required shape, has a high SA/V ratio and therefore improved osteoconductive properties due 
to enhanced ionic product dissolution and surface reactivity.10,11 One of the major 
disadvantages of this particulate form of bioactive glasses are their difficult placement and 
maintenance within the defect, together with poor mechanical properties and low 
interconnectivity.12  Until the 90s, it was difficult to manufacture these glasses in other shapes 
rather than the above mentioned, due to the required thermal processing of the compositions 
available. Two approaches were considered to circumvent this flaw: one includes the use of 
sol-gel bioactive glasses that can be manufactured as porous blocks, and the other one 
comprises melt-derived materials with “large working range compositions”,13 such as the 
“BG1” investigated in this work. These compositions have improved processing properties 
which allow them to be manufactured as fibres of different dimensions. After sintering, those 
fibres can form three-dimensional, easy to handle porous scaffolds, with macroporous 
structure, interconnected porosity, and mechanical properties more similar to those of human 
cancellous bone.12,14 
  
In the work presented here, the capacity of BG1 scaffolds to be used as bone substitute 
materials was evaluated. Initially, an in vitro analysis of their bioactivity after pre-treatment 
under two different SBF conditions to promote the formation of a bone-like apatite layer on 
their surface was performed, and the resulting deposited layers were characterized. 
Subsequently, preosteoblast initial cell attachment and morphology, as well as osteoblastic 
response in vitro were assessed, followed by an in vivo study to test their bone regeneration  
 
MATERIALS AND METHODS 
BG1 scaffold manufacturing process  
 BG1 glass fibres with an average diameter of 75 m were produced by melt spinning, 
with the following nominal composition “BG1“ (% wt): 53.6% SiO2, 13.2% CaO, 11.9% 
Na2O, 15.1% K2O, 3.2% MgO, 2.0% P2O5 and 1.0% B2O3. These fibres were further cut to a 
length of 3 mm and poured into a commercial grade II titanium mould of 8 mm in diameter 
and 10 mm height at  Inion OY (Tampere, Finland). This mould containing the fibres was 
placed into a furnace to undergo a sintering process for 25 minutes at 630°C, rendering a 
relative porosity of 70% and mean pore size of 300-400 m, as previously described.14  
 
SBF preparation and pre-treatment 
 SBF was prepared by mixing the following reagents at room temperature under 
stirring conditions, and adjusting the pH to a final range of 7.30-7.35: NaCl, Na2SO4, 
NaHCO3, KCl, K2HPO4.3H2O, MgCl2.6H2O, CaCl2, C4H11NO3, HCl (5N) (Sigma-Aldrich, 
Buchs, Switzerland). Prior to use in cell culture assays, SBF solutions were filtered sterile 
through a 0.22 m sieve (Millipore, Zug, Switzerland). The final molarity of the 1x SBF 
solutions, similar to the ionic blood plasma composition,8 is shown in Table I.  
 After sterilizing the scaffolds by dry heat at 180°C for 2 hours, the so called “1x SBF” 
and “2x SBF” scaffolds were subjected to a static four day incubation at 37°C in 1x SBF, and 
  
eight days in double concentrated SBF respectively, with media change after the first four 
days. The surface area to volume ratio was maintained at 0.5 cm-1 in both cases. Surface area 
(SA) was calculated individually for each scaffold using the following formula: 
 
  
Where w = scaffold’s weight (g), = glass density = 2.52 g/cm3, and  fibre diameter = 
0.0075 cm. After the corresponding SBF incubation period at 37°C, each scaffold was rinsed 
with sterile distilled H2O to stop any on-going reaction, washed with 70% EtOH, and 
thereafter dried overnight at 37°C. Non-treated scaffolds were used as controls.  
 
Scaffold characterization 
 Raman spectra were measured in a Renishaw 2000 micro-spectrometer equipped with 
a He/Ne laser of 632.8 nm wavelength, at EMPA, Dubendorf, Swirzerland. A Leica 50 x/0.75 
objective was used to focus the laser beam and to obtain the Raman signal. The spectra of 
three different spots from each sample (n=6) were recorded three times during 30 seconds and 
finally averaged. X-ray photoelectron spectroscopy (XPS) spectra were recorded with a 
SIGMA 2 system (ThermoFischer, England) using non-monochromatized AlK radiation at 
300 W (15 kV).  For each sample, 0-1100 eV survey spectra were recorded with an electron-
energy analyzer pass energy of 50 eV, and narrow scans at pass energy of 25 eV. The spectra 
were corrected for sample charging (eV shift), with the adventitious C1s peak at binding 
energy of 285.0 eV used as an internal reference. The XPS data were quantified by using peak 
areas (measured after Shirley background substraction) and Scofield sensitivity factors 
(R.S.F).15 
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Scanning electron microscopy 
 Bioactive glass scaffolds were subjected to scanning electron microscopy (SEM) at 
EMZ, University of Zurich, Switzerland. Briefly, at the indicated time points, scaffolds were 
washed in PBS at 37°C (Invitrogen, Basel, Switzerland), and immediately fixed in 3% 
glutaraldehyde solution for 30 min. Cellular lipids were post-fixed in 2% osmium tetraoxide 
for 15 minutes at room temperature, cells were dehydrated through increasing concentrations 
of ethanol (50-70-95-100%), and finally twice with absolute ethanol. Thereafter samples were 
critical point dried, sputter coated with 10 nm platinum and viewed using a field emission 
scanning electron microscope (Zeiss Supra 50V) operated at 5 kV. Images were obtained with 
the In-Lens detector. 
 
Cell culture on BG1 scaffolds  
 Scaffolds were pre-incubated for 1 hour in MEM-alpha with 10% (v/v) FBS, and     
100 U/ml penicillin - 100 g/ml streptomycin (Invitrogen, Basel, Switzerland). Upon media 
aspiration, MC3T3-E1 cells were seeded as a micropellet (10 l of cell suspension) to obtain 
5000 cells/cm2 on each scaffold. After 1h 30 min, culture media was added to each scaffold-
containing well. 24 h after seeding, media was exchanged and supplemented with 50 g/ml 
ascorbic acid (Sigma-Aldrich, Buchs, Switzerland), and thereafter replaced twice a week. 
MC3T3-E1 cells were chosen in this study due to their high levels of osteoblastic 
differentiation, mineralised extracellular matrix deposition, and a similar behaviour to primary 
osteoblasts, which altogether makes them a widely used model for in vitro bone formation. 16  
Alkaline Phosphatase (ALP) activity and total protein measurement 
 Scaffolds seeded with cells were rinsed in PBS after one week in culture, and placed 
into 1.5 ml polypropylene tubes, where they were crushed with a stainless steel pellet pestle. 
Subsequently, cells were lysed in 56 mM of 2-amino-2-methyl-propan-1-ol, 1 N HCl,            
  
0.2% Triton X-100 (Sigma-Aldrich, Buchs, Switzerland), at pH 10. The debris of the scaffold 
were removed by short centrifugation, and ALP activity was determined by incubation of the 
cell lysate in 20 mM of p-nitrophenylphosphate  (Fluka Chemicals, Buchs, Switzerland), 
containing 4 mM of MgCl2,  at  37°C for 10 minutes. The reaction was stopped by the 
addition of NaOH 1N. The enzymatic activity was determined by the rate of hydrolysis of     
p-nitrophenyl phosphate, which was measured at a wavelength of 405 nm and normalized to 
total protein content by the Bradford assay, using an albumin standard.16  The absorbance of 
the solution was measured using a spectrophotometer (Spectronic Genesys 2PC, 
Spectronics Instruments, NY, USA), at a wavelength of 570 nm.  
 
DNA quantification  
 In parallel with ALP activity determination, an aliquot of each cell lysate was diluted 
1:10 in Tris buffer 100 mM (Tris Ultrapure Base, ICN Biomedicals, GBMH, Germany),  
pH=6.5, 1 mM EDTA. Samples were then vortexed and thereafter centrifuged at 13000 rpm 
for 15 min at 4°C. DNA standard (Lambda DNA, Invitrogen, Basel, Switzerland) dilutions 
were prepared in ALP lysis buffer (0.2% Triton X-100 in 56 mM of 2-amino-2-methyl-
propan-1-ol,  1 N HCl (Sigma-Aldrich, Buchs, Switzerland) at pH 10, and further diluted 1:10 
in Tris buffer. Picogreen (Invitrogen, Basel, Switzerland) was applied in equal volume to each 
sample and standard DNA vial, followed by vortexing, according to the supplier’s 
instructions. Cell samples and standard DNA fluorescence were measured at 480 nm 
excitation and 520 nm emission in a BMG FLUOStar Optima (BMG Labtech GmbH).  
 
Alizarin-Red calcium nodule formation assay 
 Cell matrix calcium deposition was analyzed after two weeks in culture by staining the 
samples with Alizarin Red dye (AR-S, Sigma-Aldrich, Buchs, Switzerland). Briefly, scaffolds 
were washed once with PBS (pH 7.4), fixed during 1 h at room temperature in 70% EtOH, 
  
followed by staining with 40 mM Alizarin red in H2O, pH 4.2, during 10 minutes, while 
shaking.16 After staining, cultures were washed five times with H2O, followed by a 15 
minutes wash in PBS.  The stained matrix was imaged for qualitative analysis at 400 dpi, 
using a flat bed scanner (Epson 1640SU), and thereafter incubated in 10% 
hexadecylpyridinium chloride (Sigma-Aldrich, Buchs, Switzerland), in 10 mM sodium 
phosphate, at pH 7.0 during 1h to solubilize calcium-bound AR-S. The absorbance of the 
resulting solutions was measured at 562 nm (Spectronic Genesys 2PC, Spectronics 
Instruments, NY, USA).  
 
 pH measurement 
 The pH of the MC3T3-E1 seeded scaffold’s supernatant was measured in parallel with 
tissue culture polystyrene (TCPS) cell culture supernatant, grown in a humidified incubator at 
37C with 5% CO2 and 95% air, using an Orion 420A+ Thermo electron corporation 
electrode. pH was recorded for up to 7 days. At each time point, an aliquot of each 
supernatant was withdrawn, combined in triplicate with samples under the same conditions, 
and pH values were measured thereafter.  
 
In vivo study 
 All surgeries were performed under a protocol approved by local authorities 
(Veterinary Office, Zurich). Four full thickness bone defects were created in a rabbit calvarial 
model with a 6 mm trephine, two in the parietal and another two in the frontal sites (non-
critical size defects). The dura matter was kept intact with minimal invasion during surgery, 
while the periosteum was removed. The surgeries were performed after sedating the animals 
with Ketamine under general anaesthesia by a Halothan-N20 inhalation method. Empty 
defects were compared to those treated with commercially available Perioglassdefects 
filled with an earlier version of porous Bioglass scaffolds of 80% porosity, or the 
  
corresponding 1x SBF treated scaffolds.  After placement of the materials, the soft tissues 
were closed with sutures, and analgesia was delivered by an injection of Novalgin (50 mg/kg). 
After 4 weeks, four rabbits were sacrificed following sedation with barbiturates via an 
overdose of Ketamine, upon which the calvarial bone was excised. Subsequently, an X-ray 
image was taken from the calvarial area of each specimen to locate the middle section of the 
created defects. Thereafter, samples were dehydrated in graded ethanol series, namely 48 h in 
40% ethanol, 72 h in 70% changed every 24 h, 72 h in 96% and a final 72 h in 100% ethanol. 
Samples were placed in xylene for 72 h to solubilize the fat, infiltrated in methyl methacrylate 
(MMA) (Fluka Chemicals, Buchs, Switzerland) for 72 h, followed by three days in 100 ml 
MMA + 2 g dibenzoylperoxid at 4°C (Fluka Chemicals, Buchs, Switzerland). Afterwards, 
they were embedded in 100 ml MMA + 3 g di-benzoylperoxid + 10 ml Plastoid N or 
dibutylphtalate, and allowed to polymerize at 37°C in an air tight water bath. Histological 
sections were prepared from the middle of the defects and stained with Goldner Trichrome. 
Samples were thereafter analyzed via quantitative analysis of different tissue components by 
applying standard morphometrical techniques using a Zeiss integration plate eye piece grid.17  
Bone tissue counts (dark green) were measured directly under the light microscope at a 
magnification of 160 x, using a superimposed eyepiece test grid of 50 points and 25 cycloid 
lines. 
 
Statistical analysis 
 SPSS 12.0.1 software was used to calculate mean values and standard deviation of the 
raw data. For statistical analysis, Student’s 2-tailed t-test was applied after initial ANOVA 
test. ANOVA test was performed by using Excel software, and t-test for statistical 
significance by means of SPSS 12.0.1 software. Statistical significance was accepted for        
P < 0.05, unless otherwise indicated. 
 
  
RESULTS AND DISCUSSION 
Characterization of the surface layer deposition on SBF-treated scaffolds 
 In order to promote the bioactivity (bone bonding capacity) of the BG1 bioactive glass 
scaffolds, they were pre-treated with simulated body fluid solution (SBF) to induce the 
formation of a surface apatite-like layer8. SEM analysis was carried out to observe the 
features of the deposited layer after each SBF treatment, as well as the scaffold’s surface 
characteristics prior to treatment. SBF pre-treated scaffolds showed an apatite-like rough layer 
deposited on their fibre surfaces (1x SBF and 2x SBF), whereas non-treated scaffolds (0 SBF) 
revealed a smooth surface (Fig. 1.a). After 1x SBF treatment, sparse hemispherical nodules of 
up to 5m in diameter precipitated randomly on the scaffold's surface, at a density of        
5000 1275 per mm2 (Fig. 1.b.1). 2x SBF treated scaffolds showed a significantly higher 
density of spherical nodule formation (8500 2010per mm2, accompanied by a secondary 
globular structure with hemispherical morphology and diameters in the range of 10-20 m 
(Fig. 1.b.4). These globular structures were either independent or associated with the smaller 
spherical features (Fig. 1.b.5). In addition, some nodules aggregated forming clusters, which 
frequency of appearance was also higher after 2x SBF treatment (Fig. 2). At the nanometer 
scale, as seen at higher magnifications in Figure 1.b.3,6, both 1x SBF and 2x SBF treatments 
produced apatite-like layers with the same surface morphology, where sub-micron needle-like 
crystals typical of microcrystalline apatite were present. These SEM images confirmed the 
deposition of a rough layer onto the scaffold’s surface, with different nodule formations. 
These nodules were most abundant in the higher concentrated and longer exposure of the 2x 
SBF treatment (Fig. 2), correlating with higher ionic concentrations in solution, which are 
known to facilitate calcium-phosphate nucleation and growth of apatite crystals.2,18  
 
 
 
  
Raman vibrational modes and degree of surface crystallinity 
 Raman spectroscopy analysis was carried out to determine the nature of the surface 
layer deposited onto the scaffolds. The Raman modes of the apatite-like layer grown on the 
bioactive glass surface after immersion in SBF were similar to those of the natural bone 
mineral phase of carbonated hydroxyapatite (HCA). Characteristic peaks included the      
PO43- stretching mode at 964 cm-1 (symmetric stretching vibration of P-O from PO43- 
tetrahedral in HAP crystals), which was slightly shifted to 960 cm-1 (Fig. 3). This shift 
suggested the existence of type B carbonated hydroxyapatite, similar to that found in 
biological bone.19 The phosphatedomain included two bands at 432cm-1 and 450 cm-1, the 
latter mainly observed in the 2x SBF treated samples. The PO43- mixed phosphate 
vibration around 1070 cm-1, which also corresponds to the  stretching mode of carbonate 
ions, included the contribution of both anionic groups. Finally, the phosphate mode 
exhibited two main peaks at 589-597 cm-1 and 612 cm-1 respectively. These values were 
slightly shifted with respect to pure hydroxyapatite, which again could be due to 
modifications of the phosphate environment induced by carbonate substitution in type B 
carbonated hydroxyapatite. The spectra of the non-treated 0 SBF materials showed the 
expected silica glass main stretching modes, and no presence of calcium phosphate.20   
It has been described that a thin layer of amorphous carbonated apatite (ACP) is 
formed after 24h of bioactive glass immersion in SBF (1x SBF). This layer grows thicker with 
time in solution, turning into calcium deficient crystalline hydroxyapatite after 4 days, which 
is similar to the bone mineral phase.21  Typical vibrational modes of carbonated 
hydroxyapatite were observed after both SBF treatments performed, although pre-incubation 
in 2x SBF seemed to deposit a thicker HCA layer, as indicated by the more intense peak at      
690 cm-1. This peak has been shown to increase with immersion time and to correlate with 
thicker layer deposition.22   
 
  
Surface XPS elemental composition analysis 
 The survey spectra of the three surfaces analyzed are shown in Fig. 4, while the 
elemental composition of Ca 2p, P 2p, O 1s, Na 1s, Si 2p, K 2p and C 1s is given in Table II. 
Prior to SBF treatment, the main detected elements of the scaffolds surface, apart from 
adventitious C, were silicon, followed by K, Na and Ca, with atomic percentage values 
correlating with the initial glass composition. After treatment with SBF, Si surface 
concentration decreased sequentially for the 1x SBF samples, and more so for the 2 x SBF 
treatments, while Ca and P concentration increased in both cases, reaching similar levels. Na 
and K were no longer detectable, indicating that the substrate surface became coated with a 
calcium phosphate layer thicker than the information depth of XPS. Hydroxyapatite 
theoretical Ca, P and O elemental composition is shown as a reference included in Table II.23  
The calcium phosphate formed on SBF-treated surfaces also contained carbonate groups as 
previously indicated by Raman analysis, and its chemical composition was similar to 
biological calcium phosphates.24 In our samples, C 1s content in BG1 bioactive glass SBF 
treated scaffolds is expected to originate from both adventitious (hydrocarbon), and carbonate 
formation, whereas oxygen originates mainly from the phosphates and carbonates precipitated 
in association with Ca. Calcium deficiency as experimentally observed from Ca/P ratios of 
1.30 compared to theoretical 1.67 of crystalline hydroxyapatite for both SBF treatments,23  
could be explained by a higher carbonate content as Raman analysis already suggested. After 
1x SBF and 2x SBF treatments, the HCA-formed layer composition was very similar, except 
for lower Si content and slightly higher Ca, P and C concentration for 2x SBF-treated 
scaffolds, suggesting the presence of a thicker HCA layer.25 The only differences between the 
1x SBF and 2x SBF treatments seems to be the rougher and thicker rougher layer (at the 
microscale level) formed after the 2x SBF treatment, whereas their chemical composition as 
well as HCA structures were very similar.  
 
  
 
Cell adhesion and morphology on the different scaffold HCA surfaces  
 MC3T3-E1 pre-osteoblasts seeded onto the smooth surface of non-treated scaffolds   
(0 SBF), exhibited a rounded and flattened morphology with smooth cell extensions in contact 
with the surface (Fig. 5, 0 SBF). Alternatively, more elongated/spindle-shaped and thicker 
cells were present on the rougher surfaces (1x SBF and 2x SBF), with irregular processes that 
extended across the precipitated nodules and globular structures, especially in the 2x SBF 
case (Fig. 5.7,8).26,27  Cells seeded both on the 1x SBF and 2x SBF pre-treated scaffolds 
projected filopodia, creating individual contacts with the surface and anchoring points for cell 
adhesion. Some authors have suggested that the existence and creation of more cellular 
filopodia creates areas to which a bigger surface area of the cell can adhere and this, in turn, 
may promote faster and higher amount of mineral-like nodule formation in the longer term.28 
 After one week in culture, cells spanned the gaps among fibers, producing their own 
extracellular matrix and allowing for further cell adhesion and proliferation. Details of cells 
seeded onto 1x SBF and 2x SBF scaffolds are shown at different degrees of magnification in 
Figure 6. Note the dense extracellular matrix (ECM) layer formed with full scaffold coverage 
in Fig. 6.a,2 and Fig. 6.a.4, as well as the close association of cells with BG1 fibers through 
cell filopodia sprouting out of the cell membrane (Fig. 6.a.3). In addition, in Figure 6.b.1, a 
detail of cell anchorage onto precipitated apatite-like nodules is shown, depicting the tight 
junction and active processes occurring at these points. In Figure 6.b.2, an example of a        
2x SBF-treated scaffold completely covered by cells and ECM after one month is shown. 
Collagen fibers can be seen associated with cells and ECM covering previously formed 
carbonated hydroxyapatite nodules, in addition to newly formed ones being deposited onto 
the ECM (Fig. 6.b.2, arrows).  
 
 
  
 
Osteoblast activity on the different BG1 scaffolds 
 In order to determine whether the maturation of MC3T3-E1 pre-osteoblastic cells was 
affected by the presence of the carbonated hydroxyapatite layer and its surface features, 
osteoblast early (ALP activity) and late maturation assays (calcium deposition), were 
performed. After one week in culture, ALP activity of cells seeded onto pre-coated scaffolds 
increased twofold when compared to untreated controls (0 SBF), although no difference was 
observed between the two SBF treatments (Fig. 7.a). 2x SBF scaffold pre-treatment caused a 
50% increase in calcium nodule deposition after 2 weeks, although results were not 
significantly different to 1x SBF scaffolds or untreated ones (Fig. 7.b). Total protein content 
was higher for both SBF-treated scaffolds with induced HCA layer formation, suggesting 
more ECM production per cell (Fig. 7.c). Alternatively, DNA content was higher for the non-
treated scaffolds, indicating higher cellular proliferation in these cases (Fig. 7.d). It might be 
hypothesized that preosteoblastic cells were more sensitive to changes from bioactive glass 
smooth surface to the presence of a rough HCA layer, than to further differences observed 
once this layer was present. These results are in agreement with other studies where rough 
surfaces have been shown to promote osteoblastic maturation and protein production, while 
suppressing their growth.29,30   
 
pH-values of BG1 scaffolds cell culture supernatant 
In parallel with cell activity analysis, cell culture supernatant pH values were 
measured to detect possible media alkalinization, since bioactive glass materials are known to 
cause this effect due to their ionic products.9 The pH of all scaffold-containing samples was 
significantly higher than control media (cells grown on TCPS) at all the time points analyzed 
(P<0.01) (Fig. 8). Moreover, both SBF treatments yielded higher pH than non pre-immersed 
scaffolds after one and four days in culture (P<0.05), although no differences were observed 
  
by day 7. Small pH changes of 0.05-0.2 units, have been shown to promote osteoblastic 
activity.31,32  In addition, the ionic dissolutions products of bioactive glass have been claimed 
to have osteoproductive properties.33 In this study, even though the ionic dissolution 
composition was not assessed, the pH values of SBF-treated scaffolds’ culture media was 
higher during the first days in culture. This initial higher pH suggests an increased cationic 
content, which levelled off after one week, in the same way as other studies have shown.18 The 
fact that both SBF treatments initially rendered higher pH than non-treated scaffolds might be 
associated with partial dissolution of their HCA layers and concomitant ion leaching upon 
placement into media.  
Altogether, media alkalinization, bioactive glass ionic dissolution products and cell 
morphological features, could have translated into enhanced osteoblastic maturation as shown 
by increased ALP activity, total protein production, and slightly higher calcium deposition in 
SBF-treated samples. Further studies could include other bone specific markers, such as 
osteocalcin protein production, to confirm these findings. 
 
In vivo bone regeneration potential of porous bioactive glass scaffolds in a non-critical 
size cortical bone defect 
 Histomorphometric analysis of defects generated in the calvarial bone of rabbits 
revealed that significantly more bone had formed during a 4 week period of healing in defects 
treated with 1xSBF pre-treated bioactive glass scaffolds (24.22±1.88 %) compared to non-
treated porous bioactive glass scaffolds (15.06±5.75 %), commercially available 
Bioglass45S5 granules (Perioglass) (12.88±2.13 %), and empty non-treated defects 
(15.39±1.42 %) (Fig. 9.a, c). Another parameter important for the stable integration of the 
implant material in bone and indicative for the biocompatibility of the implant material is the 
bone to implant contact. Carbonated hydroxyapatite (HCA) pre-coated scaffolds induced 
significantly more bone deposition in direct contact to the implant when compared to the non 
  
carbonated samples (Fig. 9b). Thus, SBF-pre-treatment enhances bone formation in direct 
contact to the implant. This is also detectable in the histologies (Fig.9d) where glass fibres are 
being enclosed in the newly formed bone and ongoing bone formation, indicated by the 
presence of osteoblasts and osteoid, occurring in close proximity to the material. 
In terms of mechanical properties, both control defects and Perioglass are bound to have 
very low tensile and compression strength at this stage. This is mainly due to the lack of bone 
repair within the middle of the defect, and in the Perioglass case, also due to the granular 
nature of the biomaterial and the lack of interconnectivity. On the other hand, both bioactive 
glass scaffolds induced bone formation and direct apposition onto the scaffold’s fibres, which 
together with their three dimensional structure of the material may provide better mechanical 
support within the surrounding tissues. Bone repair and osseointegration were enhanced by 
SBF treatment (Fig. 9), which can ultimately translate into better mechanical properties, 
higher tensile strengths matching closer those of native bone and avoidance of stress 
shielding. The defect model used in this study corresponds to a cortical bone defect, with an 
elastic modulus of approximately 130 MPa. However, bioactive glass structure and the type 
of induced bone regeneration in this case is more similar to cancellous bone, which modulus 
is on average of 50 MPa. 2 
In previous studies, similar scaffolds with porosities between 45-60% were implanted 
in a pilot study into rabbit tibiae. The results obtained showed their degradation over              
6 months, as well as their osteoconductive properties and potential as bone substitute 
materials.12 Scaffold's higher porosities were chosen in this work in order to resemble more 
closely cancellous bone mechanical properties and architecture, as well as to allow for better 
vascularization.14 
 This initial in vivo assessment of porous bioactive glass scaffolds after 1 month 
revealed better performance when they were pretreated with 1x SBF, although it has yet to be 
elucidated whether these positive results translate into better bone healing in the longer term. 
  
Other authors have also reported increased bone formation with HCA-precoated bioactive 
glass, suggesting that the better in vivo performance might be caused by the increased protein 
and growth factor adsorption onto the HCA surface layer, which stimulate in turn osteoblastic 
adhesion and activity.21,34,35 Additionally, a higher pH and ionic release might occur in these 
cases, improving osteoproductive properties, as already mentioned in the previous sections.  
Overall, both the ionic dissolution of porous scaffolds and the rough surface characteristics of 
the SBF-treated scaffolds might have translated into enhanced bone regeneration, promoting 
osteoblastic adhesion, activity, and better bone bonding to them.  
To further improve the scaffolds' biological activity, osteoinductive proteins (such as 
BMP-2) can be co-precipitated within the HCA layer during SBF treatment. This approach 
could the be applied to promote bone healing in critical size defects and extend the use of 
these materials.36 
CONCLUSIONS 
 The potential of porous bioactive glass scaffolds to promote cell adhesion and activity 
in vitro, as well as bone formation in vivo was confirmed in this work, and shown to be 
enhanced by the presence of a carbonated apatite (HCA) layer on their surface after SBF 
treatment. This allows for new approaches since the material's inherent osteoconductive and 
osteopromotive properties are further enhanced, confirming its prospective use in bone 
regeneration applications. 
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Figure legends 
Figure 1. SEM images of (a) scaffold as manufactured (0 SBF) and (b) 1x SBF and 2x SBF 
pre-treated scaffolds at different magnifications as indicated. Images were obtained from two 
independent experiments, of at least 3 samples each. 
Figure 2. Nodule (including spheres and hemispheres) and cluster count after the two SBF 
treatments performed. Values shown are means ±SD of two independent experiments, n=4. 
Figure 3. Raman spectra performed after the different treatments in simulated body (SBF). 
Note the peaks at 440, 600, 950 cm-1, typical for HCA formation. Results include two 
independent experiments, n=3 each. 
Figure 4.  XPS survey spectra of the different scaffold surfaces.  
Figure 5. SEM images of MC3T3-E1 cells on untreated (a-c), 1x SBF (d-f) and 2x SBF-
treated scaffolds (g-i) respectively, after 24h in culture. 
  
Figure 6. SEM images of MC3T3-E1 cells after 1 and 4 weeks cultured on 1x SBF and 2x 
SBF treated scaffolds, respectively. b) Detail of cells cultured on 2x SBF-treated scaffolds 
after 1 week.  
Figure 7. Biological response of MC3T3-E1 cells cultured on BG1 scaffolds. a) ALP activity 
after 1 week in culture. b) Calcium nodule deposition after 2 weeks. c) Total protein 
production and d) DNA content after 1 week. Values shown are means ±SD of three 
independent experiments carried out in triplicate. (*P<0.05, compared to 0 SBF outcome).  
Figure 8. Time course of pH values in cell culture supernatants of BG1 scaffolds. Media was 
exchanged at each of the time points shown. Results shown are means ±SD of two 
independent experiments.  
Figure 9. In vivo bone regeneration with different bioactive glass compositions evaluated in a 
rabbit calvarial defect model. Bone healing in non-critical size defects was assessed 4 weeks 
after the operation.  a) Histomorphometric quantitative analysis of bone formation in the 
middle section of the defect. Results shown are mean values ±SD, of each condition (n≥3). b) 
Histomorphometric quantitative analysis of bone to implant contact. Results shown are mean 
values ±SD, of each condition (n≥3). c) Histological Goldner-Trichrome stained middle 
sections. The representative examples are from empty control, Perioglass, porous bioactive 
glass scaffold of 80% porosity, and respective porous-HCA bioactive glass scaffolds. Bone 
appears dark green, osteoid red and fibrous tissue light green). Scale bar = 1mm. d) Detail of 
representative porous-HCA bioactive glass scaffold osteoconductive properties (middle of the 
defect area in Fig. 9.c), (*P< 0.05). 
 
 
TABLES 
TABLE I. Molar composition of blood plasma and SBF. 
  
TABLE II. Surface elemental composition (atomic %) and atomic ratios Ca/P and Ca/O of 
BG1 scaffolds as manufactured (0 SBF), after SBF treatment (1x SBF, 2x SBF), and 
theoretical Hydroxyapatite (HAP) values. 
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